PTC Therapeutics, Inc. (PTCT) stock analysis
In our weekly check, PTC Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 3, red flags: 7.
About PTC Therapeutics, Inc.
PTC Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PTCT.
What our checks show for PTCT
Red flags
- Operating profit does not cover the interest bill (0.7x): interest is paid from cash or new debt.
- Earnings per share fell 44.8% a year over the last 3 years.
- The company is losing money: the net margin is -9.2%.
- Free cash flow is negative (-3.3% of revenue): the business spends more cash than it brings in.
- The stock has fallen as much as 95% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 8.8 years.
- Free cash flow is negative, so no cash is left over to cover pay in shares.
Warning signs
- The gross margin fell by 1.6 points, to 92.4%: costs are rising faster than prices.
- The price swings a lot: 42.6% annual volatility. Expect large ups and downs.
- Return on capital (ROCE) is only 5.7%.
Strengths
- Net debt is only 0.7x a year of EBITDA, but equity is negative: on the balance sheet, liabilities exceed assets.
- The net margin rose by 88.1 points over 5 years, to -9.2%.
- Operating cash flow is 0.1x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 70.9% a year over the next years.
- Analysts expect revenue to grow about 16.5% a year over the next years.
- Analysts expect the net margin to improve by 30.6 points from today's -9.2%.
Similar companies
SRRK · DNTH · MANE · ERAS · COGT · EWTX
Questions
What grade does PTC Therapeutics, Inc. (PTCT) have?
In our weekly check, PTC Therapeutics, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 12 pass, warnings: 3, red flags: 7. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of PTCT stock?
This week's biggest flags for PTC Therapeutics, Inc.: Weak interest cover, Weak EPS growth, Thin margins. In total 10 of 22 checks show a warning or a red flag.
What does PTC Therapeutics, Inc. do?
PTC Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as PTCT.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis